美国食品和药物管理局对宫脚和侧面质量螺丝的重新分类:监管历史中的案例研究
Jonathan H Sussman1,2, Ahmed Albayar3, Anissa Saylany3
1Department of Neurosurgery, Perelman School of Medicine, 3400 Civic Center Blvd, Floor 15, 19104, Philadelphia, PA, USA. jonathan.sussman@pennmedicine.upenn.edu.
Therapeutic innovation & regulatory science
|April 15, 2024
概括
美国食品和药物管理局 (FDA) 在35年后重新分类了后宫脚和侧面质量螺丝,突出了医生在医疗器械监管中的合作. 这个案例研究揭示了对FDA设备分类过程的洞察力.
科学领域:
- 脊柱外科手术 脊柱外科手术
- 医疗器械监管法规 医疗器械监管法规
- 整形外科的植入物.
背景情况:
- 后部刚性脚螺丝系统对于脊柱病理至关重要,最初于1984年被FDA分类.
- 后宫脚和侧面质量螺丝面临35年的延迟重新分类从未分类到III类,然后是II类.
- 临床实践与FDA指导方针之间的这种长期分歧源于法律挑战和有限的结果数据.
研究的目的:
- 分析了几十年来FDA对后宫脚和侧面质量螺丝的重新分类过程.
- 为了突出医生,专业组织和FDA之间的合作努力.
- 确定医疗器械分类系统的潜在改进.
主要方法:
- 对FDA设备分类的案例研究分析.
- 对历史数据,法律诉讼和临床实践演变的审查.
- 检查非标签使用在数据生成重新分类中的作用.
主要成果:
- 宫螺丝的重新分类涉及FDA,制造商,医生和患者之间的广泛互动.
- 在标签之外使用类似的胸脊柱系统为宫螺丝重新分类提供了关键数据.
- 医生和专业组织的合作有助于促进FDA重新分类.
结论:
- 医生和专业组织的合作可以显著加快FDA医疗器械重新分类.
- 这一案例强调了需要更精简的FDA分类流程,以与不断变化的医疗实践保持一致.
- 对分类系统的潜在变化可以防止临床使用和监管指南之间的长期差异.
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).


